Top Markets
Coin of the day
AmCad BioMed Corporation AmCad BioMed Corporation

AmCad BioMed Corporation

4188
Classement en actions #29619
AmCad BioMed Corporation develops computer-aided detection and diagnosis (CAD)... AmCad BioMed Corporation develops computer-aided detection and diagnosis (CAD) software devices primarily in Taiwan. It offers products for early detection and diagnosis of various diseases. The company's products include AmCAD-UT Detection, a CAD device for ultrasound images of thyroid nodules; and AmCAD-UO for detection of obstructive sleep apnea on awake patients. It also developing AmCAD-US, a software device for visualizing and quantifying statistical distributions of backscattered signals echoed by tissue compositions in the body from FDA-cleared ultrasound systems; and AmCAD-UB, an AI Solution for Breast Lesion Detection. The company was incorporated in 2008 and is based in Taipei City, Taiwan.
Prix de l'action
$0.32117018
Capitalisation boursière
$20.34M
Changement (1 jour)
-0.98%
Changement (1 an)
-34.41%
Pays
TW
Échange AmCad BioMed Corporation (4188)

Catégorie

Ratio P/B pour AmCad BioMed Corporation (4188)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de AmCad BioMed Corporation, le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour AmCad BioMed Corporation de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
3.8194 -
DE
- -
CA
4.9747 -
US
5.6622 -
US
10.2343 -
US